Christine Graham

""
  1. People /

Christine Graham

Christine Graham

Partner

""
  1. People /

Christine Graham

Christine Graham

Partner

Christine Graham

Partner

London

T: +44 (0) 20 3400 4291

VcardVcard
Download PDFDownload PDF
Print
Share

Biography

Christine is a Partner in the firm's global Antitrust and Trade Team. Christine regularly advises clients on global multijurisdictional merger control and foreign direct investment (FDI) reviews, with a particular focus on obtaining clearances before the UK and EU authorities. 

In addition to her expertise in merger control and FDI matters, Christine has significant experience of advising clients on antitrust compliance, notably in respect of distribution licensing arrangements, as well as on cartel investigations. 

Christine is widely recognised in the fields of antitrust and FDI. She is listed in the EU and competition category of The Legal 500 UK and is regarded as an “excellent leader in her field”. Christine is Vice-Chair of the ABA Antitrust Foreign Investment and National Security Committee, co-founder of the EU FDI Association and a member of the UK government’s expert panel on the UK national security and investment screening regime. Her insights on FDI and competition law are regularly featured in leading publications and speaking engagements.

Civic Involvement & Honors

  • The Legal 500 UK 2021: EU and Competition
  • Who’s Who Legal: Foreign Investment Control
  • Lexology Index - Foreign Investment Control: Recommended 

Professional Affiliations

  • American Bar Association (ABA) Antitrust Law Section Committee on Foreign Investment and National Security – Vice chair
  • Competition Law Association
  • Law Society, Competition Section

Admissions

  • England and Wales

Experience

  • Advising a healthcare investment firm, on its definitive merger agreement with a UK medical equipment manufacturer;
  • Advising a biotechnology company, on its $2.7 billion acquisition by a leading global pharmaceutical company;
  • Advising an Ireland-based biopharmaceutical company, on its $1.48 billion sale to an Italian global pharmaceutical company;
  • Advising a global digital marketplace connecting vehicle buyers and sellers, on its agreement to sell to a construction equipment auctioneer for approximately $7.3 billion;
  • Advising a world leader in modern, cloud-based connected workplace solutions, on its definitive agreement to be acquired by a global climate innovator;
  • Advising a specialty biopharmaceutical company, on its agreement to be acquired by an American biopharmaceutical company for approximately $28 billion;
  • Advising a biopharmaceutical company, on its agreement to be acquired by a global pharmaceutical and biotechnology company for approximately $1.8 billion;
  • Advising a clinical-stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases, on its definitive agreement to sell to a leading American multinational pharmaceutical company for $6.7billion;
  • Advising a leading provider of cloud-based infrastructure for cryptocurrency security, on its agreement to sell to an American multinational online payment company;
  • Advising a global leader in digital consumer intelligence and social media listening, on its agreement to sell to a public relations, marketing and social media management technology company, for $450 million;
  • Advising is an American interactive data visualization software company (Tableau) on its agreement to sell to a cloud-based software company in a $15.7 billion all-stock transaction;
  • Advising an American computer software company on its sale to a global American technology company in an approximately $2.6 billion all-cash transaction;
  • An investment consultancy firm in response to the UK Financial Conduct Authority’s asset management market study and subsequent market investigation by the UK Competition and Markets Authority;
  • A subsidiary of a supermajor on its competition law pleadings before the High Court in relation to the termination of a suite of agreements relating to the production and transportation of gas from offshore fields to the UK National Transmission System;
  • A leading pharmaceutical manufacturer in a European Commission investigation into the supply of medicines;
  • A large telecommunications operator on an appeal before the UK Competition Appeal Tribunal in relation to fair access to infrastructure and margin squeeze claims and;
  • Various companies on merger control filings before the European Commission and the CMA

Related Insights

News
Sep 08, 2025
BCLP Strengthens Global Antitrust and Foreign Investment Practice with Lateral Hire